Timothy J. Hahn, Ph.D.
Senior Vice President, Process Technology

Timothy J. Hahn, Ph.D.Dr. Hahn is Senior Vice President, Process Technology with responsibility for adjuvant technology and manufacturing and antigen process and analytical development. Dr. Hahn has 28 years of commercial vaccine and antibody manufacturing experience and a proven track record with clinical and commercial products, process innovation, technology transfer, facility start-up, GMP compliance, and regulatory inspections. Dr. Hahn joined Novavax in June 2011 as Senior Vice President, Manufacturing and Process Development and was named Senior Vice President, Global Manufacturing Operations with responsibility for production sites in the U.S. and Europe. Prior to joining Novavax, he was Vice President of Antibody Manufacturing and later Vice President of Vaccine Manufacturing at MedImmune, LLC, with responsibilities for sites in the U.S. and Europe. Prior to MedImmune, he spent more than 15 years in vaccine manufacturing with Merck & Co. Dr. Hahn received his Bachelor of Science degree in Chemical Engineering from Lehigh University and his Master of Science and Doctorate degrees in Chemical Engineering from Stanford University.